Skip to content

Efficacy of Boswellia carteri B. on mixed urinary incontinence in women

Efficacy of a traditional preparation based on Boswellia carteri B. on clinical symptoms of mixed urinary incontinence in women aged 55 to 80 years old

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190310042998N1
Enrollment
120
Registered
2019-06-07
Start date
2019-05-04
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mixed urinary incontinence. Mixed incontinence

Interventions

Intervention 1: Intervention group: The recipient of the traditional product based on Boswellia carteri B.(A mixture of 83 mg powdered powdered rhizome, 79 Kg powdered root, 55 mg ginger powder, 83 m

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: Women 55 to 80 years old patients with mixed urinary incontinence

Exclusion criteria

Exclusion criteria: patients with Neurogenic bladder patients with Pelvic organ prolapse with stage>=2 patients with urinary and vaginal infections Drug use for this disorder and mental disorders and hormonal medications in the last month Contraindication of anticholinergic use by the patient Drug addiction History of pelvic radiotherapy and chemotherapy History of urogenital Cancer Having psychological disorders such as Alzheimer's Severe digestive problems

Design outcomes

Primary

MeasureTime frame
Frequency of urinary leakage. Timepoint: At the beginning of the study, week 2, week 4 and week 6. Method of measurement: ICIQ-SF questionnaire.;Urinary incontinence leakage rate. Timepoint: At the beginning of the study, week 2, week 4 and week 6. Method of measurement: ICIQ-SF questionnaire.;Urine leakage time. Timepoint: At the beginning of the study, week 2, week 4 and week 6. Method of measurement: ICIQ-SF questionnaire.

Secondary

MeasureTime frame
Quality of Life. Timepoint: At the beginning of the study, week 2, week 4 and week 6. Method of measurement: ICIQ-SF and I-QOL questionnaires.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKarbalaiee Shahrbabaki Mahboubeh

Kerman University of Medical Sciences

m.karbalaiee@kmu.ac.ir+98 34 3211 0860

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026